ProKidney Corp. (PROK)
NCM · Common · CUSIP G7S53R104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for PROK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G7S53R104 (prev. G8253W109 )
Market Cap
Large Cap
IPO
6/30/2021 · $10.00/share
Previous Symbol
DNAC (changed 7/18/2022)
Previous Name
Social Capital Suvretta Holdings Corp. III
Business: ProKidney Corp. is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient’s own cells isolated from the patient intended for treatment.

Company Contact

CEO
Bruce Culleton
CFO
James Coulston
Headquarters
2000 Frontis Plaza Blvd., Ste 250, Winston-Salem, NC 27103
Phone
336-999-7028
Investor Relations
Daniel Ferry, LifeSci Advisors · 336-999-7028 · Daniel@lifesciadvisors.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »